"Pharmaceutical Industry Influence on Nonprofit Organizations: The Case of the National Community Pharmacists Association"
Read "Pharmaceutical Industry Influence on Nonprofit Organizations: The Case of the National Community Pharmacists Association" on RadioNOVO
"Pharmaceutical Industry Influence on Nonprofit Organizations: The Case of the National Community Pharmacists Association"
[!CDATA[The pharmaceutical industry is known for its lobbying efforts, but it also funds nonprofit organizations to promote industry interests. The National Community Pharmacists Association (NCPA) is a prime example of this practice, receiving significant financial support from drug industry trade associations and corporations. Major supporters of the NCPA include AmeriSourceBergen and PhRMA, with other drug industry sponsors contributing between $5,000 and $200,000 annually. The NCPA claims to represent U.S. pharmacists and advocates for increased regulation of pharmacy benefit managers (PBMs), who negotiate drug prices for insurers. The pharmaceutical lobby has long pushed for more oversight of PBMs. President Donald Trump recently focused on drug prices, promising to lower costs by requiring pharmaceutical companies to sell drugs in the U.S. at the lowest global price. He signed an executive order to enforce this policy, but legal experts question its feasibility. In conclusion, the pharmaceutical industry supports nonprofit organizations like the NCPA to advance its agenda. The NCPA advocates for pharmacist interests and regulatory oversight of PBMs, aligning with industry priorities. President Trump's efforts to reduce drug prices have sparked debate over the feasibility and impact of his executive order.]]